Core Insights - West Pharmaceutical Services, Inc. (NYSE:WST) is recognized as one of the 14 Best Dividend Growth Stocks to Buy and Hold in 2026 [1] Group 1: Market Demand and Growth Drivers - KeyBanc projects that injectable GLP-1 drugs will continue to drive demand for West Pharmaceutical, with limited risk to oral weight loss drugs through 2030 [2] - The firm estimates that the oral version of Wegovy will only contribute approximately 200 basis points to the total GLP-1 market share by 2030, indicating a conservative outlook on oral drug adoption [2] - West Pharmaceutical's drug components business now accounts for 47% of total revenue, reflecting strong demand for components used in GLP-1 weight-loss and diabetes drugs [3] Group 2: Product Offerings - West Pharmaceutical supplies essential medical components such as stoppers, plungers, and delivery systems, which are critical for the safe storage and administration of injectable medicines, including vaccines and biologics [4]